Breast Cancer

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA
FDA
Lorazepam Is Voluntarily Recalled by Maker
08/17/2017
Lorazepam Oral Concentrate has been voluntarily recalled by Amneal Pharmaceuticals.
08/17/2017
FDA
FDA
Lorazepam Is Voluntarily Recalled by Maker
08/17/2017
Lorazepam Oral Concentrate has been voluntarily recalled by Amneal Pharmaceuticals.
08/17/2017
Statins
Statins
Pravastatin/Bupropion Mix-Up Leads to Recall
08/14/2017
The FDA has announced a recall of pravastatin tablets due to mislabeling.
08/14/2017
Statins
Statins
Pravastatin/Bupropion Mix-Up Leads to Recall
08/14/2017
The FDA has announced a recall of pravastatin tablets due to mislabeling.
08/14/2017
Statins
Statins
Pravastatin/Bupropion Mix-Up Leads to Recall
08/14/2017
The FDA has announced a recall of pravastatin tablets due to mislabeling.
08/14/2017
Obesity
Obesity
FDA Issues Warning of Gastric Balloon-Related Deaths
08/11/2017
In response to several reported deaths, the FDA has issued a warning to alert health care providers of potential mortality risk related to intragastric balloon systems.
08/11/2017
Obesity
Obesity
FDA Issues Warning of Gastric Balloon-Related Deaths
08/11/2017
In response to several reported deaths, the FDA has issued a warning to alert health care providers of potential mortality risk related to intragastric balloon systems.
08/11/2017
Obesity
Obesity
FDA Issues Warning of Gastric Balloon-Related Deaths
08/11/2017
In response to several reported deaths, the FDA has issued a warning to alert health care providers of potential mortality risk related to intragastric balloon systems.
08/11/2017
Hepatitis C
Hepatitis C
FDA Approves New Option for Hepatitis C Genotypes 1-6
08/03/2017
The FDA has approved a new option for the treatment of hepatitis C infection genotypes 1-6.
08/03/2017
Hepatitis C
Hepatitis C
FDA Approves New Option for Hepatitis C Genotypes 1-6
08/03/2017
The FDA has approved a new option for the treatment of hepatitis C infection genotypes 1-6.
08/03/2017